Taiwan FDA registration 73ddbb9d2575f1148bae3c59b7436ea4

APID voice blood glucose test system

TW: 愛彼德語音血糖測試系統
Taiwan flagTaiwan·Risk Class 2·Metalgen Biotechnology Co., Ltd·Registered Feb 03, 2012 – Feb 03, 2022Cancelled
Registration details
Analysis ID
73ddbb9d2575f1148bae3c59b7436ea4
Customs Code
DHY00500351606
Company information
Manufacturer Country
Taiwan, Province of China
Authorized Representative
Metalgen Biotechnology Co., Ltd
Product details
Intended Use
This product can be quantified by fresh fingertip whole blood and can be used by diabetics or healthcare professionals (for single use only).
Product Type (Level 1)
A Clinical chemistry and clinical toxicology
Product Type (Level 2)
A.1345 Glucose Test System
Import Information
Domestic
Dates and status
Registration Date
Feb 03, 2012
Expiry Date
Feb 03, 2022
Cancellation Date
Apr 12, 2024
Cancellation information
Status
Logged out
Reason
許可證已逾有效期
About this record

Access comprehensive regulatory information for APID voice blood glucose test system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 73ddbb9d2575f1148bae3c59b7436ea4 and manufactured by Metalgen Biotechnology Co., Ltd. The authorized representative in Taiwan is Metalgen Biotechnology Co., Ltd.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices